Discover Roche’s latest innovations in cancer immunotherapy

CEO on cancer immunotherapy

Roche CEO Severin Schwan talks about our commitment and leadership in this exciting field.

Linking T-cells and cancer cells

When the body’s own immune system fails, T-cell bispecific antibodies help T-cells spring back into action and attack cancer cells.

Unleashing the T-Cell army

Learn how our research and development team managed to separate 200 known cancer types into three primary immune profiles.

The PD-L1 pathway

The role of the immune system is to protect the body from foreign invaders. PD-L1 can help tumour cells evade the immune surveillance.

Tags: Science